<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39331940</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>39</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Adult patients with severe respiratory syncytial virus infections in the emergency department.</ArticleTitle><Pagination><StartPage>e39265</StartPage><MedlinePgn>e39265</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e39265</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000039265</ELocationID><Abstract><AbstractText>Respiratory syncytial virus (RSV) is a seasonal virus known to cause significant morbidity in pediatric patients; however, morbidity in adult patients has not been well investigated. We aimed to characterize adult patients with RSV infection in the emergency department (ED) and their clinical course. During the winter term 2022/23, all adult ED patients were screened for RSV, severe acute respiratory syndrome coronavirus type 2, and influenza infection using point-of-care polymerase chain reaction tests. All symptomatic RSV+ patients were further characterized based on their clinical presentation and course. A group comparison between RSV+ inpatients and RSV+ outpatients was conducted. The potential risk factors for inpatient treatment were evaluated using univariate and multivariate analyses. Of the 135 symptomatic RSV+ patients, 51.9% (70/135) were inpatients. Their length of stay were 9.4 (±10.4) days. Inpatients had a significantly higher mean age, lower oxygen saturation, higher leukocyte count, and higher C-reactive protein levels than outpatients. Among the preconditions, pulmonary diseases, tumors, and immunosuppression were significantly more frequent in the inpatient group. Thirty percent (21/70) of the inpatients required ICU treatment, 11% (8/70) required mechanical ventilation, and 9% (6/70) died. Malaise (P = .021, odds ratio 8.390) and detection of pulmonary infiltrations (P &lt; .001, odds ratio 12.563) were the only independent predictors of inpatient treatment in the multivariate analysis. Our data show that RSV is a medically relevant pathogen among adult ED patients, often requiring inpatient treatment. In particular, elderly patients with some medical preconditions seem to be more prone to a severe course of infection requiring inpatient treatment. Lower respiratory tract involvement, proven by pulmonary infiltrates, seems to be crucial for a more severe disease course.</AbstractText><CopyrightInformation>Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fistera</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2502-0123</Identifier><AffiliationInfo><Affiliation>Center of Emergency Medicine, University Hospital Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kramer</LastName><ForeName>Christian M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Center of Emergency Medicine, University Hospital Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manegold</LastName><ForeName>Randi Katrin</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Center of Emergency Medicine, University Hospital Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elsner</LastName><ForeName>Carina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dittmer</LastName><ForeName>Ulf</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taube</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, University Medicine Essen - Ruhrlandklinik, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kill</LastName><ForeName>Clemens</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center of Emergency Medicine, University Hospital Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Risse</LastName><ForeName>Joachim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center of Emergency Medicine, University Hospital Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018357" MajorTopicYN="Y">Respiratory Syncytial Virus Infections</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="Y">Emergency Service, Hospital</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>18</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>18</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39331940</ArticleId><ArticleId IdType="pmc">PMC11441945</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000039265</ArticleId><ArticleId IdType="pii">00005792-202409270-00083</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rima B, Collins P, Easton A, et al. . ICTV virus taxonomy profile: pneumoviridae. J Gen Virol. 2017;98:2912–3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5775899</ArticleId><ArticleId IdType="pubmed">29087278</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose EB, Wheatley A, Langley G, Gerber S, Haynes A. Respiratory syncytial virus seasonality - United States, 2014-2017. MMWR Morb Mortal Wkly Rep. 2018;67:71–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5772804</ArticleId><ArticleId IdType="pubmed">29346336</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH. Respiratory syncytial virus. In: Red Book: 2021–2024 Report of the Committee on Infectious Diseases. Itasca, IL: American Academy of Pediatrics; 2021:628.</Citation></Reference><Reference><Citation>Li Y, Wang X, Blau DM, et al. . Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399:2047–64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7613574</ArticleId><ArticleId IdType="pubmed">35598608</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam HH, Ison MG. Respiratory syncytial virus infection in adults. BMJ. 2019;366:l5021.</Citation><ArticleIdList><ArticleId IdType="pubmed">31506273</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee N, Lui GC, Wong KT, et al. . High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis. 2013;57:1069–77.</Citation><ArticleIdList><ArticleId IdType="pubmed">23876395</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis. 2004;189:233–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">14722887</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivey KS, Edwards KM, Talbot HK. Respiratory syncytial virus and associations with cardiovascular disease in adults. J Am Coll Cardiol. 2018;71:1574–83.</Citation><ArticleIdList><ArticleId IdType="pubmed">29622165</ArticleId></ArticleIdList></Reference><Reference><Citation>Branche AR, Saiman L, Walsh EE, et al. . Incidence of respiratory syncytial virus infection among hospitalized adults, 2017-2020. Clin Infect Dis. 2022;74:1004–11.</Citation><ArticleIdList><ArticleId IdType="pubmed">34244735</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan CB, Walsh EE, Peterson DR, Lee FE, Falsey AR. Risk factors for respiratory failure associated with respiratory syncytial virus infection in adults. J Infect Dis. 2009;200:1242–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2896971</ArticleId><ArticleId IdType="pubmed">19758094</ArticleId></ArticleIdList></Reference><Reference><Citation>Whimbey E, Champlin RE, Englund JA, et al. . Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant. 1995;16:393–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8535312</ArticleId></ArticleIdList></Reference><Reference><Citation>Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med. 2020;173:362–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7281624</ArticleId><ArticleId IdType="pubmed">32491919</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Q, Liu J, Liu Q, et al. . Global percentage of asymptomatic SARS-CoV-2 infections among the tested population and individuals with confirmed COVID-19 diagnosis: a systematic review and meta-analysis. JAMA Netw Open. 2021;4:e2137257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8672238</ArticleId><ArticleId IdType="pubmed">34905008</ArticleId></ArticleIdList></Reference><Reference><Citation>Munywoki PK, Koech DC, Agoti CN, et al. . Frequent asymptomatic respiratory syncytial virus infections during an epidemic in a rural Kenyan household cohort. J Infect Dis. 2015;212:1711–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4633757</ArticleId><ArticleId IdType="pubmed">25941331</ArticleId></ArticleIdList></Reference><Reference><Citation>Quarg C, Jorres RA, Engelhardt S, Alter P, Budweiser S. Characteristics and outcomes of patients hospitalized for infection with influenza, SARS-CoV-2 or respiratory syncytial virus in the season 2022/2023 in a large German primary care centre. Eur J Med Res. 2023;28:568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10699044</ArticleId><ArticleId IdType="pubmed">38053110</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackerson B, Tseng HF, Sy LS, et al. . Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults. Clin Infect Dis. 2019;69:197–203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6603263</ArticleId><ArticleId IdType="pubmed">30452608</ArticleId></ArticleIdList></Reference><Reference><Citation>Belongia EA, King JP, Kieke BA, et al. . Clinical features, severity, and incidence of RSV illness during 12 consecutive seasons in a community cohort of adults &gt;/=60 years old. Open Forum Infect Dis. 2018;5:ofy316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6306566</ArticleId><ArticleId IdType="pubmed">30619907</ArticleId></ArticleIdList></Reference><Reference><Citation>Fistera D, Hoelscher T, Pabst D, et al. . Evaluation of a new COVID-19 triage algorithm in the emergency department including combined antigen and PCR-testing: a case-control study. Medicine (Baltimore). 2022;101:e31278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9592145</ArticleId><ArticleId IdType="pubmed">36281158</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall CB, Long CE, Schnabel KC. Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis. 2001;33:792–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11512084</ArticleId></ArticleIdList></Reference><Reference><Citation>Colosia AD, Yang J, Hillson E, et al. . The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: a systematic review. PLoS One. 2017;12:e0182321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5552193</ArticleId><ArticleId IdType="pubmed">28797053</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>